Fate Therapeutics (FATE) just announced earnings March 3, 2020, with a beat on EPS and on revenue. The company’s GAAP EPS loss of 37 cents beat estimates by two cents. Revenue of $2.8 million beat estimates by $1.1 million, and was up 68.7% year over year. Related: Fate Therapeutics Reports Fourth Quarter 2019 Financial Results […]

Over the last trading session, shares of SolarEdge Technologies (SEDG) were slightly at $127.20 a share. Year over year, the stock is now up nearly 245%. That’s double the return of the Invesco Solar ETF (TAN). It also beats the S&P 500 return of 18%. SolarEdge Technologies, designs, develops, and sells direct current (DC) optimized inverter […]